Suppr超能文献

人血小板中的P2Y1受体在药理学上与P2Y(ADP)受体不同。

P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.

作者信息

Fagura M S, Dainty I A, McKay G D, Kirk I P, Humphries R G, Robertson M J, Dougall I G, Leff P

机构信息

Department of Pharmacology, Astra Charnwood, Loughborough, Leicestershire.

出版信息

Br J Pharmacol. 1998 May;124(1):157-64. doi: 10.1038/sj.bjp.0701827.

Abstract
  1. In the present study we have classified the receptor(s) mediating increases in intracellular calcium concentration ([Ca2+]i) in human washed platelets and compared the pharmacological profile obtained with that observed in Jurkat cells, stably transfected with a bovine P2Y1-receptor. 2. The P2Y1-receptor antagonist, adenosine-3'-phosphate-5'-phosphate (A3P5P), competitively antagonized agonist responses in both Jurkat cells, and in platelets with similar affinities (pK(B) of 5.8 and 6.0, respectively). 3. The selective P2Y(ADP) antagonist, AR-C66096, exhibited partial agonism in the Jurkat cells with an affinity (pK(A)) of 4.9. This value is consistent with its known P2Y1-receptor activity. In platelets, AR-C66096 at a concentration (0.1 microM) approximately 100 fold greater than its known P2Y(ADP) receptor affinity, had no effect on ADP-induced increases in [Ca2+]i. 4. The ability of adenine nucleotide analogues to elevate [Ca2+]i in the Jurkat cells was also determined. The rank order of agonist potency (p[A]50) was: 2-MeSADP (8.3)>2-ClATP (7.8)>ADP (7.5)=2-MeSATP (7.4)>ATPgammaS (6.5)>ATP (6.2), with ATP appearing to be a partial agonist. 5. The same rank order of potency was observed when similar experiments were performed in platelets. However, the absolute potencies of all the agonists and the intrinsic activities of both ATPgammaS and ATP were lower in platelets. 6. The operational model of agonism was used to test whether the agonist concentration-effect profiles obtained in these two cell types could be explained on the basis of differences in receptor reserve. The analysis indicated that the data obtained in platelets closely resembled that predicted for a low density or poorly coupled P2Y1-receptor system. 7. The hypothesis that the observed partial agonist behaviour of ATP was the result of receptor activation by contaminating ADP with concomitant receptor blockade by ATP, was tested in the platelet system. This hypothesis was supported by a theoretical analysis, which yielded an affinity value for ATP similar to that obtained previously at P2Y1-receptors. 8. In summary, the results of this study indicate that human washed platelets contain P2Y1-receptors which mediate increases in [Ca2+]i and that this receptor population is pharmacologically distinct from P2Y(ADP)-receptors.
摘要
  1. 在本研究中,我们对介导人洗涤血小板细胞内钙浓度([Ca2+]i)升高的受体进行了分类,并将所获得的药理学特征与在稳定转染牛P2Y1受体的Jurkat细胞中观察到的特征进行了比较。2. P2Y1受体拮抗剂腺苷-3'-磷酸-5'-磷酸(A3P5P)在Jurkat细胞和血小板中均能竞争性拮抗激动剂反应,亲和力相似(pK(B)分别为5.8和6.0)。3. 选择性P2Y(ADP)拮抗剂AR-C66096在Jurkat细胞中表现出部分激动作用,亲和力(pK(A))为4.9。该值与其已知的P2Y1受体活性一致。在血小板中,AR-C66096的浓度(0.1 microM)比其已知的P2Y(ADP)受体亲和力大约高100倍,对ADP诱导的[Ca2+]i升高没有影响。4. 还测定了腺嘌呤核苷酸类似物在Jurkat细胞中升高[Ca2+]i的能力。激动剂效力(p[A]50)的排序为:2-甲硫基ADP(8.3)>2-氯ATP(7.8)>ADP(7.5)=2-甲硫基ATP(7.4)>ATPγS(6.5)>ATP(6.2),ATP似乎是部分激动剂。5. 在血小板中进行类似实验时,观察到相同的效力排序。然而,所有激动剂的绝对效力以及ATPγS和ATP的内在活性在血小板中较低。6. 采用激动作用的操作模型来测试在这两种细胞类型中获得的激动剂浓度-效应曲线是否可以基于受体储备的差异来解释。分析表明,在血小板中获得的数据与低密度或偶联不佳的P2Y1受体系统预测的数据非常相似。7. 在血小板系统中测试了ATP观察到的部分激动剂行为是由污染的ADP激活受体并伴随ATP受体阻断所致的假设。这一假设得到了理论分析的支持,该分析得出的ATP亲和力值与先前在P2Y1受体处获得的值相似。8. 总之,本研究结果表明,人洗涤血小板含有介导[Ca2+]i升高的P2Y1受体,并且该受体群体在药理学上与P2Y(ADP)受体不同。

相似文献

引用本文的文献

7
Historical perspective on ADP-induced platelet activation.ADP诱导血小板活化的历史视角。
Purinergic Signal. 2011 Sep;7(3):283-92. doi: 10.1007/s11302-011-9227-x. Epub 2011 Apr 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验